<label id="mboud"><meter id="mboud"></meter></label>

        <rt id="mboud"><small id="mboud"><strike id="mboud"></strike></small></rt>
        咨詢熱線

        15000266580

        當(dāng)前位置:首頁(yè) >產(chǎn)品中心>細(xì)胞庫(kù)>人腫瘤細(xì)胞、癌細(xì)胞>Panc 03.27 人胰腺癌細(xì)胞

        Panc 03.27 人胰腺癌細(xì)胞

        簡(jiǎn)要描述:CRL-2549 Panc 03.27
        人胰腺癌細(xì)胞,原代細(xì)胞|細(xì)胞系|細(xì)胞株|菌種;
        細(xì)胞庫(kù)管理規(guī)范,
        提供的細(xì)胞株背景清楚,提供參考文獻(xiàn)和培養(yǎng)條件!
        Panc 03.27 人胰腺癌細(xì)胞

        • 產(chǎn)品型號(hào):
        • 廠商性質(zhì):生產(chǎn)廠家
        • 更新時(shí)間:2025-07-19
        • 訪  問(wèn)  量:2013

        產(chǎn)品分類

        Product Category

        詳細(xì)介紹

        CRL-2549 Panc 03.27 人胰腺癌細(xì)胞

        ATCC® Number: CRL-2549™ Price: $417.00

        Designations: Panc 03.27

        Depositors: EM Jaffee

        Biosafety Level: 1

        Shipped: frozen

        Medium & Serum: See Propagation

        Growth Properties: adherent

        Organism: Homo sapiens (human)

        Morphology: epithelial

        Source: Organ: pancreas

        Disease: adenocarcinoma

        Cellular Products: cytokeratins 7 and 18

        Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimay responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.


        CRL-2549 Panc 03.27 人胰腺癌細(xì)胞

        Tumorigenic: Yes

        Oncogene: K-ras + (wild-type)

        Antigen Expression: MHC class I +; MHC class II - [50655]

        Blood type A; Rh+

        DNA Profile (STR): Amelogenin: X

        CSF1PO: 10,11

        D13S317: 11,12

        D16S539: 12

        D5S818: 12,13

        D7S820: 8,13

        THO1: 6

        TPOX: 8,9

        vWA: 16,17

        Age: 65 years

        Gender: female

        Ethnicity: White

        Comments: Panc 03.27 is a pancreatic adenocarcinoma epithelial cell line derived in 1995 from a primary tumor removed from the head-of-the-pancreas of a female with pancreatic adenocarcinoma.The cells have a reported plating efficiency of 80%.

        Propagation: ATCC complete growth medium: RPMI 1640 medium with 2 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM HEPES, and 1.0 mM sodium pyruvate and supplemented with 10 Units/ml human insulin, 85%; fetal bovine serum, 15%

        Atmosphere: air, 95%; carbon dioxide (CO2), 5%

        Temperature: 37.0°C

        Subculturing: Protocol:

        1.Remove and discard culture medium.

        2.Briefly rinse the cell layer with 0.25% (w/v) Trypsin - 0.53 mM EDTA solution to remove all traces of serum which contains trypsin inhibitor.

        3.Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).

        Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37C to facilitate dispersal.

        4.Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.

        5.Add appropriate aliquots of the cell suspension to new culture vessels.

        6.Incubate cultures at 37C.

        Subc*tion Ratio: A subc*tion ratio of 1:3 to 1:4 is recommended

        Medium Renewal: Every 2 to 3 days

        Preservation: Freeze medium: culture medium, 95%; DMSO, 5%

        Storage temperature: liquid nitrogen vapor phase

        Doubling Time: 37.5 hrs

        Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2001

        recommended serum:ATCC 30-2020

        0.25% (w/v) Trypsin - 0.53 mM EDTA in Hank' BSS (w/o Ca++, Mg++):ATCC 30-2101

        Cell culture tested DMSO:ATCC 4-X

        References: 50655: Jaffee EM, et al. Development and characterization of a cytokine-secreting pancreatic adenocarcinoma vaccine from primary tumors for use in clinical trials. Cancer J. Sci. Am. 4: 194-203, 1998. PubMed: 9612602


        CRL-2549





















        產(chǎn)品咨詢

        留言框

        • 產(chǎn)品:

        • 您的單位:

        • 您的姓名:

        • 聯(lián)系電話:

        • 常用郵箱:

        • 省份:

        • 詳細(xì)地址:

        • 補(bǔ)充說(shuō)明:

        • 驗(yàn)證碼:

          請(qǐng)輸入計(jì)算結(jié)果(填寫(xiě)阿拉伯?dāng)?shù)字),如:三加四=7
        聯(lián)系方式

        郵箱:xiangfbio@163.com

        地址:上海市虹口區(qū)四平路710號(hào)7層

        咨詢熱線

        400-821-8510

        (周一至周日9:00- 19:00)

        在線咨詢
        • 掃一掃 微信咨詢

        Copyright©2025 上海復(fù)祥生物科技有限公司 All Right Reserved    備案號(hào):滬ICP備10013034號(hào)-2     sitemap.xml
        技術(shù)支持:化工儀器網(wǎng)    管理登陸
        主站蜘蛛池模板: 亚洲性日韩精品一区二区三区| 亚洲人精品亚洲人成在线| 亚洲无码一区二区三区| 国产亚洲精品免费视频播放| 2022免费国产精品福利在线| 日本免费网站在线观看| 中文有码亚洲制服av片| 在线免费观看中文字幕| 亚洲熟妇久久精品| 日本黄页网站免费| 粉色视频免费入口| 亚洲精品第一国产综合精品99 | 亚洲爆乳成av人在线视菜奈实| 老司机福利在线免费观看| 性做久久久久免费观看| 精品亚洲成a人在线观看| 24小时日本韩国高清免费| 亚洲AV成人精品网站在线播放 | 一个人看的免费视频www在线高清动漫 | 热99RE久久精品这里都是精品免费| 免费一区二区视频| 国产精品玖玖美女张开腿让男人桶爽免费看 | 男女猛烈无遮掩视频免费软件| 日韩免费精品视频| 亚洲精品午夜无码电影网| 免费网站看av片| 久久亚洲国产成人影院网站 | 亚洲国产成人一区二区精品区| 秋霞人成在线观看免费视频| 一区国严二区亚洲三区| 亚洲va乱码一区二区三区| 久久精品一区二区免费看| 亚洲性69影院在线观看| 99热在线精品免费播放6| xxx毛茸茸的亚洲| 免费一区二区视频| 青青草原1769久久免费播放| 亚洲日韩一区二区一无码| 我的小后妈韩剧在线看免费高清版| 亚洲日韩精品国产一区二区三区| 亚洲狠狠爱综合影院婷婷|